technetium tc 99m sestamibi has been researched along with Lewy Body Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inui, Y; Iwata, N; Katada, K; Kosaka, K; Manabe, Y; Sarai, M; Sato, T; Toyama, H | 1 |
1 other study(ies) available for technetium tc 99m sestamibi and Lewy Body Disease
Article | Year |
---|---|
Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Female; Heart; Humans; Imaging, Three-Dimensional; Iofetamine; Lewy Body Disease; Male; Perfusion; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2007 |